Intravenous Neonatal Central Access Safety Trial
NCT:NCT05537389 · COMPLETED
廣告
NCT IDNCT05537389
狀態COMPLETED
開始日期2023-01-01
完成時間2026-09-07
SponsorUniversity of Turin, Italy (OTHER)
First posted
Last updated
簡要摘要
Particulate contamination due to infusion therapy (administration of parenteral nutrition and medications) carries a potential health risk for infants in neonatal intensive care units (NICU). In-line filtration is increasingly used in critically-ill infants but its benefits, by preventing micro-particle infusion in neonates, remain to be demonstrated. In-line filters in the intravenous administration sets prevent the infusion of particles, which may reduce infectious complications.
官方來源
在 ClinicalTrials.gov 上查看 →資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。